Эффективность комплексной терапии бактериального вагиноза, ассоциированного с папилломавирусной инфекцией, с применением активированной глицирризиновой кислоты

1. Cherpes T.L., Hillier S.L., Meyn L.A., Busch J.L., Krohn M.A. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex. Transm. Dis. 2008; 35(1): 78-83. https://dx.doi.org/10.1097/OLQ.0b013e318156a5d0
2. Wiesenfeld H.C., Hillier S.L., Krohn M.A., Landers D.V., Sweet R.L. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 2003; 36(5): 663-8. https://dx.doi.org/10.1086/367658
3. Rose J.B., Jiménez-Cisneros B., eds. Water and Sanitation for the 21st Century: Health and Microbiological Aspects of Excreta and Wastewater Management (Global Water Pathogen Project). Available at: https://www.waterpathogens.org/about-the-book
4. Centers for Disease Control and Prevention (CDC). Clinical Overview of HPV. Available at: https://www.cdc.gov/hpv/hcp/clinical-overview/index.html (accessed February 6, 2025).
5. Centers for Disease Control and Prevention (CDC). About HPV. Available at: https://www.cdc.gov/hpv/about/index.html (accessed February 6, 2025)
6. Martins B.C.T., Guimarães R.A., Alves R.R.F., Saddi V.A. Bacterial vaginosis and cervical human papillomavirus infection in young and adult women: a systematic review and meta-analysis. Rev. Saude Publica. 2022; 56: 113. https://dx.doi.org/10.11606/s1518-8787.2022056004412
7. Peng Y., Tang Q., Wu S., Zhao C. Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis. BMC Infect. Dis. 2025; 25(1): 708. https://dx.doi.org/10.1186/s12879-025-10851-4
8. Gillet E., Meys J.F., Verstraelen H., Bosire C., De Sutter P., Temmerman M. et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect. Dis. 2011; 11: 10. https://dx.doi.org/10.1186/1471-2334-11-10
9. Amabebe E., Anumba D.O.C. Mechanistic insights into immune suppression and evasion in bacterial vaginosis. Curr. Microbiol. 2022; 79(3): 84. https://dx.doi.org/10.1007/s00284-022-02771-2
10. Farr A., Swidsinski S., Surbek D., Tirri B.F., Willinger B., Hoyme U. et al. Bacterial vaginosis: guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/028, June 2023). Geburtshilfe Frauenheilkunde. 2023; 83(11): 1331-49. https://dx.doi.org/10.1055/a-2169-8539
11. Sherrard J., Wilson J., Donders G., Mendling W., Jensen J.S. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS. 2018; 29(13): 1258-72. https://dx.doi.org/10.1177/0956462418785451
12. Lachyan A., Khunger N., Panda P.S. Bacterial vaginosis and biofilms: therapeutic challenges and innovations – a narrative review. Indian J. Dermatol. Venereol. Leprol. 2024; 90(6): 750-4. https://doi.org/10.25259/IJDVL_1322_2023
13. Рахматулина М.Р., Большенко Н.В., Липова Е.В. Опыт применения активированной глицирризиновой кислоты при вульвовагинитах, цервицитах и генитальной папилломавирусной инфекции. Акушерство и гинекология. 2019; 9: 153-8.
14. Качалина О.В., Матузкова А.А. Активированная глицирризиновая кислота в комплексном лечении пациенток с вагинитами и дисбиозом: результаты многоцентрового исследования. Акушерство и гинекология. 2023; 3: 115-20.
15. Шалепо К.В., Спасибова Е.В., Будиловская О.В., Крысанова А.А., Хуснутдинова Т.А., Чеберя А.С., Чеберя А.Р., Савичева А.М. Оценка действия препарата «Эпиген Интим» на бактериальные пленки, сформированные вагинальными микроорганизмами in vitro. Акушерство и гинекология. 2024; 2: 125-33.
16. Atashili J., Poole C., Ndumbe P.M., Adimora A.A., Smith J.S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008; 22(12): 1493-501. https://dx.doi.org/10.1097/QAD.0b013e3283021a37
17. Allsworth J.E., Lewis V.A., Peipert J.F. Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 National health and nutrition examination survey data. Sex. Transm. Dis. 2008; 35(9): 791-6. https://dx.doi.org/10.1097/OLQ.0b013e3181788301
18. Wahl S.M., McNeely T.B., Janoff E.N., Shugars D., Worley P., Tucker C. et al. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis. 1997; 3(S1): 64-9. https://dx.doi.org/10.1111/j.1601-0825.1997.tb00377.x
19. Cherpes T.L., Melan M.A., Kant J.A., Cosentino L.A., Meyn L.A., Hillier S.L. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin. Infect. Dis. 2005; 40(10): 1422-8. https://dx.doi.org/10.1086/429622
20. Briselden A.M., Moncla B.J., Stevens C.E., Hillier S.L. Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J. Clin. Microbiol. 1992, 30(3): 663-6. https://dx.doi.org/10.1128/jcm.30.3.663-666.1992
21. Шуршалина А.В., Кречетова Л.В., Зиганшина М.М., Сухих Г.Т. Локальное действие Эпиген интим спрей (глицирризиновая кислота) при вирусных инфекциях половых органов. Акушерство и гинекология. 2009; 3: 63-5.
22. Selyutina O.Y., Polyakov N.E. Glycyrrhizic acid as a multifunctional drug carrier – from physicochemical properties to biomedical applications: a modern insight on the ancient drug. Int. J. Pharm. 2019; 559: 271-9. https://dx.doi.org/10.1016/j.ijpharm.2019.01.047

Поступила 21.10.2025

Принята в печать 28.10.2025